However, extending their research to the group of CML patients in TFR, they noticed that despite the unblocking of the SAMHD1 phosphorylation pathway due to the withdrawal of TKI, the frequency of proviral integration was more than 12-fold reduced [152]. The gene discussed is SAMHD1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.